Key Events This Week
06 Apr: Week opens at Rs.3.32
07 Apr: Valuation shifts signal elevated price risk
10 Apr: Mojo rating upgraded from Strong Sell to Sell
10 Apr: Week closes at Rs.3.29 (-0.90%) vs Sensex +5.34%

Zenith Health Care Ltd Upgraded to Sell on Improved Technicals and Valuation
2026-04-10 08:13:04Zenith Health Care Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 9 April 2026, reflecting a nuanced improvement in its technical outlook and valuation metrics despite ongoing fundamental challenges. The micro-cap pharmaceutical company’s Mojo Score rose to 31.0, signalling a cautious but more favourable stance among analysts.
Read full news article
Zenith Health Care Ltd Valuation Shifts Signal Elevated Price Risk
2026-04-07 08:01:04Zenith Health Care Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen a marked shift in its valuation parameters, raising questions about its price attractiveness amid a deteriorating financial profile and a challenging market backdrop. The company’s price-to-earnings (P/E) ratio has surged to 39.77, pushing its valuation grade from fair to expensive, while its price-to-book value (P/BV) stands at 2.38, signalling a premium compared to historical and peer averages.
Read full news article
Five Consecutive Losses Push Zenith Health Care Ltd to a New 52-Week Low
2026-03-30 16:06:56For the fifth consecutive session, Zenith Health Care Ltd has closed lower, hitting a fresh 52-week low of Rs 2.23 on 30 Mar 2026. This marks a steep decline of 21.85% over the last three days alone, underscoring persistent selling pressure despite pockets of positive financial data.
Read full news article
Zenith Health Care Ltd Valuation Shifts Signal Elevated Price Risk Amid Weak Returns
2026-03-20 08:00:23Zenith Health Care Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen a notable shift in its valuation parameters, moving from fair to expensive territory. Despite a recent 5.66% intraday price gain, the company’s elevated price-to-earnings (P/E) and price-to-book value (P/BV) ratios, alongside deteriorating profitability metrics, raise questions about its price attractiveness relative to peers and historical benchmarks.
Read full news articleZenith Health Care Ltd Falls 7.58%: 3 Key Factors Driving the Weekly Decline
2026-03-14 17:00:04
Key Events This Week
Mar 2: Stock hits 52-week low at Rs.3.02 amid valuation worries
Mar 4: Price stagnates at Rs.3.10 despite Sensex decline
Mar 5: Further dip to Rs.3.03 on mixed market signals
Mar 6: New 52-week low of Rs.3.01 recorded

Zenith Health Care Ltd Falls to 52-Week Low of Rs.2.5 Amidst Continued Downtrend
2026-03-10 12:40:36Zenith Health Care Ltd, a player in the Pharmaceuticals & Biotechnology sector, has touched a new 52-week low of Rs.2.5 today, marking a significant decline amid ongoing market pressures and company-specific factors. The stock has underperformed its sector and broader market indices, reflecting persistent challenges in its financial and technical performance.
Read full news article
Zenith Health Care Ltd Falls to 52-Week Low of Rs.2.82
2026-03-09 13:20:49Zenith Health Care Ltd, a player in the Pharmaceuticals & Biotechnology sector, touched a new 52-week low of Rs.2.82 today, marking a significant decline in its stock price amid broader market weakness and company-specific financial concerns.
Read full news articleFormat of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
11-Apr-2026 | Source : BSEFormat of the Annual Disclosure to be made by an entity identified as a Large Corporate.
| Sr. No. | Particulars | Details |
| 1 | Name of Company | Zenith Healthcare Ltd |
| 2 | CIN NO. | L24231GJ1994PLC023574 |
| 3 | Report filed for FY | 2025-2026 |
| Details of the Current block (all figures in Rs crore): | ||
| 4 | 2 - year block period (Specify financial years)* | FY 2024-25 and FY 2025-26 |
| 5 | Incremental borrowing done in FY (T)(a) | 0.00 |
| 6 | Mandatory borrowing to be done through debt securities in FY (T) (b) = (25% of a) | 0.00 |
| 7 | Actual borrowing done through debt securities in FY (T)(c) | 0.00 |
| 8 | Shortfall in the borrowing through debt securities if any for FY (T - 1) carried forward to FY (T) (d) | 0 |
| 8 | Quantum of (d) which has been met from (c)(e)* | 0 |
| 9 | Shortfall if any in the mandatory borrowing through debt securities for FY (T) { after adjusting for any shortfall in borrowing for FY(T - 1) which was carried forward to FY(T)}(f) = (b) - [(c) - (e)]{ If the calculated value is zero or negative write nil}* | 0 |
| Details of penalty to be paid if any in respect to previous block (all figures in Rs crore): | |
| 2 - year Block period (Specify financial years) | FY 2024-25 and FY 2025-2026 |
| Amount of fine to be paid for the block if applicable Fine = 0.2% of {(d) - (e)}# | 0.00 |
| Name of the Company Secretary :- | Mihir Shah |
| Designation :- | Company Secretary and Compliance Officer |
| Name of the Chief Financial Officer :- | Prashant Gupta |
| Designation : - | Chief Financial Officer |
Date: 11/04/2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
11-Apr-2026 | Source : BSESubmission of Declaration of RTA under Regulation 74(5) of Depositories and Participants Regulation 2018.
Closure of Trading Window
24-Mar-2026 | Source : BSEIntimation for Trading Window Closure
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available







